HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill Takes Small Step Toward More Nanotech Research, Commercialization

This article was originally published in The Rose Sheet

Executive Summary

Congress is recognizing the need for direction in nanotechnology research, but researchers and consumer safety advocates say more is needed to spur further nanotech commercialization and adequately protect the public from potential dangers

You may also be interested in...



House Kicks Off New Year With Bill To Sharpen Federal Nanotech Plan

The House Committee on Science and Technology will consider legislation crafted to provide strategic direction to the federal research program for nanotechnology

House Kicks Off New Year With Bill To Sharpen Federal Nanotech Plan

The House Committee on Science and Technology will consider legislation crafted to provide strategic direction to the federal research program for nanotechnology

U.S. Spending On Nanotech Research Questioned With Goods Flooding Market

Europe is committing nearly twice as many dollars to nanotechnology risk research as the United States; meanwhile, consumer products engineered with materials on the nano scale are reaching the market at a rate of 3 to 4 per week, according to the Project on Emerging Nanotechnologies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel